SANOFI AVENTIS US FDA Approval ANDA 085204

ANDA 085204

SANOFI AVENTIS US

FDA Drug Application

Application #085204

Application Sponsors

ANDA 085204SANOFI AVENTIS US

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL200MG0SLO-PHYLLINTHEOPHYLLINE

FDA Submissions

ORIG1AP1979-11-14
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1982-07-15
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1982-07-15
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1983-02-14
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1985-07-26
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1984-01-10
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1984-01-10
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1984-07-30
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1985-11-01
LABELING; LabelingSUPPL16AP1988-10-05
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1990-06-18
LABELING; LabelingSUPPL19AP1990-07-26
LABELING; LabelingSUPPL20AP1990-11-27
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1999-04-29

Submissions Property Types

ORIG1Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL14Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL23Null0

CDER Filings

SANOFI AVENTIS US
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 85204
            [companyName] => SANOFI AVENTIS US
            [docInserts] => ["",""]
            [products] => [{"drugName":"SLO-PHYLLIN","activeIngredients":"THEOPHYLLINE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"SLO-PHYLLIN","submission":"THEOPHYLLINE","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.